Marshall H Woodworth bought $9,940 of MTVA
Chief Financial Officer at NeuroBo Pharmaceuticals, Inc.. 14,200 shares at an average of $0.70, traded Jun 4, 2025, filed Jun 4, 2025.
Score components
- +22RoleCFO
- 0Trade size$10k at market
- +6Relative to holdingsHoldings up 47%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.7%, 3m -2.5%, 6m -12.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-056382, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 4, 2025 | POpen-market purchase Common Stock | +14,200 | $0.70 | $9,940 | 44,279 | Jun 4, 2025 |
Related signals
Other insiders at NeuroBo Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | MTVAbuy NeuroBo Pharmaceuticals, Inc. | Dong-A St Co., Ltd owner | $3.3M 4,647,887 shares | +87% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.